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Abstract 
Intracranial vessel wall imaging may be accomplished with high-field (7T) magnetic 
resonance (MRI). To determine its feasibility, a 7T MR protocol was defined using 
Polyvinyl-alcohol cryogel (PVA-C) phantom vessels and healthy subjects. 
A 2D matrix construct of PVA-C vessel phantoms of different diameters and wall 
thicknesses was scanned. Three observers measured the phantom images, one of which three 
times. Physical measurements were performed using a digital caliper. Ten volunteers were 
scanned using three different MRI sequences (TSE-3D, FLAIR, MPRAGE). Imaging 
assessment was performed in different circle of Willis (COW) segments. Reliability and 
accuracy of the measurements was analyzed by inter and intraobserver correlation and by 
comparison to physical measurements.  
Phantom measurements showed overall high inter and intraobserver reliability and accuracy 
(ICC≅0.9). However, precision diminished for smaller vessels (<3mm). TSE was superior on 
vessel wall definition compared with FLAIR on both, phantoms and volunteers. On healthy 
subjects, vessel wall was recognized consistently, but precise definition of distal COW 
segments was not achieved. Vessel wall was significantly overestimated (p<0.05) when 
comparing to intracranial vessel diameters from prior studies due to partial volume effects.  
 
Vessel wall imaging is feasible with 7T MR. However, precision and definition decreases 
consistently with the vessel caliber. PVA adequately mimics 7T MR vessel wall imaging 
properties.   
Keywords 
Vessel wall imaging, High-Field (7T) MR, Polyvinyl-alcohol cryogel (PVA-C), intracranial 
vasculopathy.  
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Chapter 1  
1 Background 
1.1 Introduction 
Stroke is the third leading cause of death in Canada and affects around 50.000 people in 
Canada each year. Also known as cerebrovascular accident (CVA), it is the rapid loss of 
brain function due to disturbance in the blood supply to the brain. This can be due to 
either ischemia (lack of blood flow) caused by blockage of the vessel (thrombosis, 
arterial embolism) or hemorrhage as a result from rupture of a blood vessel or an 
abnormal vascular structure. It is intimately related to the health of the blood vessels in 
the brain, and therefore to the vessel wall pathology (i.e intracranial atherosclerosis, 
vasculitis and other vascular abnormalities). However, intracranial vessel wall imaging 
still remains one of the elusive frontiers of stroke and vasculopathy research, as 
contemporary clinical imaging is confined to luminal study. Vessel wall pathology must 
be inferred from either the morphology of the lumen, or the displacement of surrounding 
cerebrospinal fluid signal and brain parenchyma. Assessment of the lumen solely, it has 
been demonstrated to be insufficient, especially during the early stages of vasculopathy, 
when vessel remodeling and wall alterations can occur without compromising luminal 
size1. Luminography-based methods therefore may underestimate the presence of 
intracranial arterial pathology2-6. Intracranial atherosclerosis, dissection, vasculitis, and 
early aneurysm formation could yield similar appearances with either: catheter 
angiography; computed tomographic angiography (CTA); or standard magnetic 
resonance angiography (MRA). The inability to correctly diagnose these pathologies 
could lead to adverse treatment events or unnecessary surgical exploration. With 
conventional MRI techniques only pathological conditions, such as enhancement of the 
intracranial vessel wall with vasculitis and significant luminal narrowing with severe 
atherosclerosis can be detected5. Studies have shown a high prevalence of atherosclerotic 
changes of intracranial arteries. However the most important cause of ischemic cerebral 
infarcts is still thought to be embolic, and is not well known the role of intracranial vessel 
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wall atheroma (atherosclerosis) in their occurence. An important reason for this lack of 
knowledge might be the absence of imaging methods to depict the intracranial vessel 
wall. Intracranial arterial aneurysm pathogenesis has been debated for many years and 
remains unclear. These lesions can suppose life threatening risks to patients, so 
understanding their cause and progression is important for choosing the adequate 
treatment. The general assumption is that the arterial blood flow generates an aneurysmal 
herniation of the vessel wall that can eventually rupture. Thin aneurysm wall thickness 
(AWT) is thought to carry an elevated risk of intracranial aneurysm rupture. Obtaining 
information about the AWT might help to predict the risk of rupture for these lesions, and 
therefore an adequate management avoiding unnecessary preventive treatments. 
Moreover, a better understanding of aneurysms might be obtained on evaluation of the 
morphological characteristics of the vessel wall and might help to distinguish among the 
diverse diseases that generate intracranial aneurysms. Distinguish between more 
conventional saccular aneurysms and intracranial dissecting aneurysm (IDA) that involve 
different natural histories and different wall pathological features (e.g., double lumen, 
intimal flap, and intramural hematoma on IDA) might be also of great importance for the 
clinical decision-making process.  
Overall, accurate visualization of vessel wall could help in the understanding of 
underlying pathological features and potentially guide treatment choices for intracranial 
vascular diseases.  
1.2 Intracranial vessel wall imaging 
Standard 1.5T magnetic resonance imaging (MRI) has been used to study extracranial 
carotid arteries and vessel wall morphology for atherosclerosis and dissection. Novel 
imaging protocols allow visualization of the vessel wall, plaque, and blood7. When 
applied to the intracranial circulation, the resolution is not sufficient and the reliability of 
the images diminishes. The intracranial vessels are smaller and located deep in the brain, 
and need a higher resolution than used for carotid vessel wall imaging6. Moreover, circle 
of Willis (COW) vessels do not have a single orientation, which prohibits the use of thick 
slices perpendicular to the vessel orientation, as is normally done in imaging of the 
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carotid artery wall7,8. The extracranial carotid arteries measure 7-10 mm in diameter, and 
taper intracranially to range from 4-5mm in diameter proximally to 1-2mm more distally, 
throughout the Circle of Willis. Only 13 studies to date5,9-21 have attempted to visualize 
both healthy and diseased intracranial vessel walls, compared to over eighty publications 
per year on the extracranial carotid arteries. Small vessel size prevents accurate 
visualization at 1.5T. Eleven of the 13 studies utilize 3T MRI9-19, and only 2 studies 
explored 7T MRI5,21. Brain vessel wall MRI has been demonstrated11,12, but again, in 
most of the cases, the spatial resolution utilized so far makes it difficult to assess contrast 
or structure inside the wall thickness. Although 3T MRI could provide imaging resolution 
to resolve some pathologies that produce a thickened vessel wall, 7T MRI has superior 
signal to noise, and contrast to noise characteristics compared to 3T, and thereby 
providing better spatial resolution and visualization of intracranial vessel walls5,20-24.  
1.3 Imaging at High Field (7T) MRI 
Imaging at high magnetic field strengths has many advantages, such as increased signal-
to-noise ratio (SNR) and spatial resolution. An increase in the field corresponds to an 
increase in SNR, that follows a linear relation with the value of the field23. An increase in 
SNR results in a higher image quality, higher speed of image acquisition, and higher 
spatial resolution. Also, longer T1 and T2 relaxation times at higher fields result in higher 
blood/tissue contrast25,26.   
However, there are certain concerns regarding the effects of magnetic fields of such high 
strength on human tissue. At ultra high field, there is a rapid increase in the quantity of 
RF (radiofrequency) energy deposited; which is proportional to the square of the value of 
the main magnetic field25,26. During an MR procedure, the patient absorbs a portion of the 
transmitted RF energy, which may result in tissue heating and other adverse effects, such 
as alterations in visual, auditory and neural functions. The Specific Absorption Rate 
(SAR), measured in Watts/kg, is the RF power absorbed per unit mass of tissue. Strict 
limits to the SAR levels are imposed by patient safety international regulations and SAR 
measurements must be monitored during a scan to ascertain that levels do not approach 
the limit26.  
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1.4 Study hypothesis and objectives  
Hypothesis:  
We hypothesize that using an ultra high field (7T) magnetic resonance imaging a fine 
resolution, such that intracranial vessel wall at the level of the circle of Willis can be 
precisely define, could be accomplished.  
Objectives:  
1. Using an ex vivo phantom model of simulated intracranial vessels, define a 7T 
MR protocol to approximate the signal characteristics, determine its precision and 
accuracy and delimit an image resolution threshold. 
2.   Optimize the MR protocol on human volunteers, maximized for spatial resolution, 
with the aim of obtaining reliable intracranial vessel wall imaging, and defining in-
vivo achievable cerebral vessel limits on MRI, in terms of image contrast and spatial 
resolution. 
 
5 
 
 
Chapter 2  
2 Polyvinyl alcohol (PVA) phantoms 
2.1 Introduction 
2.1.1 Hypothesis and objectives 
We hypothesize that polyvinyl alcohol cryogel (PVA-C) phantoms could simulate 
imaging characteristics of intracranial vessels at ultra high field (7 tesla) magnetic 
resonance imaging (MRI) with fine definition and good spatial resolution.  
 
The objective is to develop a tissue-mimicking construct of the intracranial vessels using 
formulations of PVA-C that closely simulate the size, texture and imaging properties of 
vascular human tissue at 7T MR. 
2.1.2 Phantoms 
Phantoms are used in medical imaging research to replace real tissue in studies where in 
vivo models are inappropriate or as a first step to allow initial stages of the investigation 
without directly subjecting in vivo models. Phantoms can be modeled on anatomical 
features, like vessels and vascular trees, or mechanical structures that behave 
appropriately, such as a pulsating vessel wall. One benefit to modeling these features 
instead of using anatomical specimens is that the phantom can be made accurately, with a 
known structure that is used as ‘truth’. Other benefits to phantom use include their long-
term structural stability, the ease of registering multiple phantom images to one another 
in subsequent studies, the ability to perform long imaging procedures without concern for 
subject motion or discomfort and also to test and develop new medical methods27. Also, 
phantoms usually have a simpler structure than anatomical models. This allows for a 
simplification of the problem, by restricting the number of experimental variables. The 
structure can be focused to a specific problem, or the role of the phantom can be limited 
to a single process in question27.  
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2.1.3 PVA-C ideal vascular mimicking phantom material 
Desired properties of a tissue-mimicking phantom material for imaging include: 
comparable relaxation times to those of human tissue, robustly processable, non-
hazardous, stable for long periods of time, readily available, inexpensive, and easy to 
handle. Polyvinyl alcohol cryogel (PVA-C) is an ideal material fulfilling all of these 
characteristics27.  
Polyvinyl alcohol (PVA) is a widely used, non-toxic, industrial compound, often 
employed in papermaking, textiles, glue in food packaging or for a variety of coatings. It 
is white (colorless) and odorless and could be supplied as beads, powder or as solutions 
in water27,28.  
When using the appropriate PVA and water solution, this material can be easily formed 
into a gel possessing tissue-mimicking properties. This gel solution of PVA (PVA 
hydrogel) can be submitted to a cross-link process by the formation of crystallites during 
repeated freeze–thaw cycles27,29  to become polyvinyl alcohol cryogel. Effects of varying 
the concentration of PVA powder in the aqueous solution or the number and/or timing of 
the freeze/thaw cycles (FTC) used in its preparation can be easily exploited to tweak the 
properties of the resulting material to suit the desired application27,29-31. PVA-C as a 
synthetic polymer with tissue-mimicking capability, has been used in constructs that 
simulate liver, brain, heart valves, stomach, bladder and prostate for research and 
teaching purposes32.  It has also demonstrated to be an ideal vascular phantom material 
due to its excellent properties such as signal intensity, relaxation times, elasticity, and 
strength32-35.  
PVA-C vascular phantoms have been previously used for imaging purposes in 1.5T and 
3T MR, but there is no previous experience using high field 7T MR.  Therefore this 
project represents the first attempt to experiment with PVA-C in high field strength MRI.  
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2.2 Methods 
2.2.1 PVA preparation 
2.2.1.1 PVA liquid solution preparation 
Commercial PVA powder, Aldrich 341584 Poly(vinyl alcohol) powder [Mw 180,000; 
99+% hydrolyzed] (Sigma-Aldrich Co. LLC. Saint Louis, MO, USA) was used to make 
our PVA liquid solutions. To make 10% PVA liquid solution, 40 g of PVA powder and 
360 g of de-ionized water were mixed in a 1 litre flat bottom flask, along with a stir bar. 
A biocide was added (0.2% Germall Plus powder) to avoid biological contamination. The 
mixture was stirred to break any aggregates of powder. To fully dissolve the powder, the 
solution was brought to 85-90 ◦ C for 2 hours using a Heating mantle (Resin reaction 
flask mantle. Glas-Col,LLC. Terre Haute, USA). During this process the mixture was 
continuously stirred with an automatic mixer blade (Fig 1).  The resulting clear gel, PVA 
hydrogel (PVA-H), was transferred to a beaker container for its storage and was cooled to 
room temperature for at least 1 to 3 hours. This cooling stage was important to ensure the 
formation of a homogeneous gel. When the PVA-H was cool, the beaker was covered 
with a plastic wrap to prevent air drying the surface. The same process was repeated to 
make 15% PVA liquid, this time mixing 60 g of PVA powder and 340 g of de-ionized 
water.  
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Figure 1: Heating mantle and automatic mixer blade set up.  
 
2.2.1.2 PVA cryogel (PVA-C) 
The PVA-H was allowed to rest for 12–24 h for air bubbles to rise to the surface (thin 
crust) and be removed. To form the PVA hydrogel solution into a solid phantom, the 
PVA gel was first poured into the appropriate moulds taking care to avoid forming 
bubbles. If the PVA-H seemed still to present an excessive amount of bubbles the beaker 
glass containing the gel was placed on a hotplate (Thermolyne® Cimarec® 2 –stirring 
hotplate. Sigma-Aldrich Co. St Louis, MI, USA) and slowly stirred until reach a 
temperature of around 50-60ºC. Around 1 hour after that, it was feasible to use the gel 
solution to fill the moulds.   
 
The phantoms were kept well sealed (zip lock bag) in order to mantain some humid 
environment, so that they will not dry during the freeze-thaw cycle stage. Phantoms were 
placed in a Temperature Environmental Chamber (TestEquity 107 Benchtop Temperature 
Chamber). The desired number of cycles was chosen (Fig 2). Every cycle cooled the 
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phantoms from 20ºC to -20ºC at 0.1 degree C per minute, for a total freeze-thaw stage 
time of 15 hours for every cycle. Adequate temperature variations were recorded during 
the process and checked once the cycles were completed. This monitoring was performed 
with a temperature and humidity datalogger (Reed C-342/345. Center Thermo recorders) 
obtaining a numerical and graphic reading on a PC interface program (“Slim-Com” RS-
232. Test link SE342 version 2.2.1.0) (Fig 2). The resulting PVA-C phantoms were 
carefully removed from the moulds and stored in clean, de-ionized water. With care, the 
phantoms can be kept almost indefinitely this way. In particular, replacing the water 
regularly, helps to extend the useful life of the phantoms.  
 
Figure 2: Freeze-Thaw cycle process. a) Temperature Chamber selected for 2FTC.              
b) 2FTC graph (30h) showing the recorded temperature and humidity during each cycle. 
2.2.2 Selecting PVA optimal formulation 
In order to choose the optimal formulation of PVA for our vessel phantoms and 
characterize this material in terms of its imaging properties at 7T, we decided to construct 
cylindrical solid phantoms. Plastic tubing, with inner diameter of 27 mm, outer diameter 
of 28.5 mm and a length of 11.5 cm for a 50cc volume capacity, was used as mould for 
the phantoms. Three phantoms were created using 10% PVA solution and another set of 
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three using 15% PVA solution (Fig 3). Both PVA formulations were subjected to 
different freeze-thaw cycles, from 2 (30 hours) to 4 (60 hours) cycles. The resulting 
cylindrical phantoms were scanned at the 7T MR (T1 and T2 sequences) to obtain the 
different relaxation times (see table 1).  A CPMG sequence was used for T2 and an 
inversion-recovery method for T1.  
       
Figure 3: Solid cylindrical phantoms. a) Plastic tubing mold + PVA-C phantoms. b) Solid 
cylindrical phantom sample (10% PVA, 3FTC) 
 
 
T1	  times	   10%	  PVA	   15%	  PVA	   T2	  Times	   10%	  PVA	   15%	  PVA	  	  2	  FTC	   1542	  ms	   1633	  ms	   2FTC	   128ms	   115ms	  	  3FTC	   1627	  ms	   1388	  ms	   3FTC	   115ms	   91ms	  4FTC	   1527	  ms	   1290	  ms	   4FTC	   100ms	   81ms	  
     Table 1: T1 and T2 times at 7T MR as a function of FTC and PVA-C concentration (%). 
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As expected, based in other MRI studies (on 1.5 and 3T MR) using PVA , T1 and T2 
values decreased with the number of freeze-thaw cycles27,32 (See Fig 4).   
 
The measured relaxation T1 and T2 times were also found reasonable and biologically 
relevant to human brain tissue and to exvivo intracranial vessels relaxation times at 7T 
MR  obtained from previous experiments8,21.   
 
 
 
 
 
 
 
 
Figure 4: MR relaxation coefficients, T1 and T2, for 10% PVA-C at 1.5T (from Surry et al©27)  
 
To decide the ideal formulation for our purpose we took into account the T1,T2 
relaxation times, the mechanical workability of the material and the effects of the freeze-
thaw cycles on the wall thickness. It is known from other research studies that PVA-C 
vascular phantoms wall thickness decreases with freeze-thaw cycles. This results from 
PVA crystallites growing in size after each freeze-thaw cycle and hence, expelling free 
water from the gel. A shrinkage from around 2% after two cycles to approximately 25% 
after five cycles has been documented32.  
 
Considering  an adequate range of T1 and T2 times, ideal mechanical and manageability 
properties, making it more convenient for its manipulation, and trying to minimize the 
11
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non measurable and non controllable shrinkage factor, it was decided 10% PVA-C 
subjected to 2FTC to be the optimal formulation for our study.  
 
2.2.3 Intracranial vessel phantoms. 2D matrix construction 
2.2.3.1 2D matrix construction 
Several published papers have tried to measure the geometry of the circle of Willis 
(COW) and to elucidate the intracranial vessels diameter as well as their wall thickness. 
Most of them are post-mortem and histopathological studies36-40, although different 
techniques have been used including various imaging techniques37,41-44 . In general, 
intracranial arteries have a lower wall:lumen ratio than extracranial arteries36.  Some of 
these studies suggest a mean wall thickness of 0.6 ± 0.12 mm and 0.51 ± 0.08 mm in the 
basilar and middle cerebral arteries, respectively36,42,44-47. Considering the average outside 
diameter (OD) of this 2 vessels from those literature sources (middle cerebral artery: 2.8-
3.5mm [2.59mm], basilar artery: 2.6-3.4mm [3.24mm]), it is estimated a wall 
thickness/OD ratio of around 15-20% in the intracranial vessels. The diameters of our 
phantoms were based on this averaged values obtained from the different sources found 
in the literature36-47.  
We decided to create several vessel-like phantoms with decreasing diameter and wall 
thicknesses to obtain a 2D matrix model that could cover the whole spectrum of the 
intracranial vasculature.  A total of 24 vessel phantoms of different calibers were built 
from 8mm as the largest outside diameter to 2mm as the smallest diameter. A total of 
three pig vessels (common femoral artery) (Fig 5) were also harvested and included in the 
model for tissue characterization and comparison with the phantoms.  
13 
 
 
                                     
Figure 5: Pig left common femoral artery prior to be harvested.  
To create the phantoms, clear acrylic and stainless steel (SS) multi-component vessel 
molds were constructed. The acrylic material was used as a cast for the SS tubing 
(Precision Miniature Stainless Steel Tubing. McMaster-Carr. Cleveland, OH, USA). Each 
vessel mold had an OD tube that fit on a preformed cavity on the side pieces of the 
acrylic cast, and an ID tube slide fitting into the OD tube.  The acrylic cast consisted of 3 
pieces with the central part containing the support for the OD tube. In the right end piece 
a threaded hole was made to suit a barbed plastic tube connector made to inject the PVA 
solution. The molds were designed to obtain a vessel length of approximately 5cm. With 
disassembly these molds allowed us to create the walled vessel phantoms and remove 
them fairly easily from the molds for their later use.  (Figure 6) 
Four different molds were created for each OD vessel. By varying the ID tube size we 
obtained four different wall thicknesses, 25%, 20%, 15% and 10% (OD/wall thickness 
ratio), that should represent the average diameter of the intracranial vessels wall.  
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Figure 6: Walled vessel phantom. a) PVA-C vessel showing the average length of 5cm. b) 
Vessel phantom mold partially disassembled. 
 
PVA-H was carefully injected into each mold using a 5cc syringe (Fig 7a).  The molds 
were again placed in sealing bags to avoid drying out during the freeze-thaw cycle stage, 
and submitted to 2 FTC in the Temperature Chamber. Adequate temperature variations 
were again recorded during the process and checked once the cycles were completed (Fig 
7b). The resulting PVA-C phantoms were carefully removed from the moulds and stored 
in labelled containers in clean de-ionized water.  
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Figure 7: Making of vessel phantoms. a) Filling the mold with PVA-H b) Phantoms in the 
temperature chamber ready for the freeze-thaw cycle stage with the temperature recorder 
(arrow). 
2.2.3.2 2D matrix assembling: Supporting fixtures. Agarose 
solution. 
To complete the 2D matrix construction a customized supporting fixture for the phantoms 
was designed and built with a stereolithography (SLA)  3D printer (SLA-5000 3D 
Systems, Inc. Rock Hill, SC, USA).  The model consisted of a total of 27 cylindrical rods 
of acrylic-like material. These rods had coincident diameter with the inner diameter of the 
vessel phantoms and served as the vessel lumen contrast on the phantoms imaging.  
Three extra rods were added to fit the pig vessels. The phantoms were positioned, such 
that ‘axial’ slices, as defined by the head coil orientation, could show a circular cross-
section of each vessel and cylinder in the image. (Fig 8) 
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Figure 8: 2D matrix model. a,b) 2D matrix model design for its SLA 3D printing. c,d) 2D 
matrix customized supporting fixture. Two vessel phantoms were placed in their respective 
rods as an example (see arrows). 
The vessel phantoms and the pig vessels were placed on their respective rods on the 
supporting fixture. In order to obtain image contrast it was decided to embed the 
phantoms with a surrounding material that could mimic the brain tissue and give us good 
differentiation between tissue classes. Although many different types of brain phantom 
materials have been proposed, agar and agarose are the most commonly used48-51. T2 
relaxation time of both agarose and agar gel have demonstrated to be similar to that of 
human and brain tissue (40–150 ms human tissue equivalent on 3T MR and 45-55ms 
brain tissue equivalent on 7T MR)26,48, with the possibility of being adjusted by altering 
the consistency of the gel (i.e. the concentration of agarose or agar)48,52. Previous 
experience26 using agarose as brain tissue mimicking material used a concentration of 
2%. Therefore, we opted to prepare a 2% agarose gel solution as our imaging contrast 
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tissue. The required quantity of agarose gel powder (A6013 Sigma-Aldrich  Agarose 
Type I, Low EEO) was weighed accurately using an electronic balance (MS1062-S 
Precision Balance. Mettler-Toledo Canada Inc. Mississauga, ON, Canada) and the 
powder was dissolved in distilled water. The solution was mixed well with a stirrer and 
heated to a temperature of 85-90 °C using a hotplate (Thermolyne® Cimarec® 2 –stirring 
hotplate. Sigma-Aldrich) until the mixture became viscous, but trying to avoid many 
bubbles. The agarose solution was then poured into the mold embedding the vessels and 
allowed to cool down to room temperature.  
With this last step the 2D matrix model construction was finished and the phantom was 
ready to be scanned. (Fig 9) 
                 
Figure 9: Different pictures of the 2D matrix construction after its completion (a and d 
without the outside part of the mounting fixture). The phantom has all its components 
(PVA-C walled vessels and acrylic-like mounting fixture, embedded in the agarose gel) and 
is ready for scan. 
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2.2.4 7T MR phantom imaging 
MRI scanning was carried out on a 7-Tesla Agilent/Siemens human neuro MRI System 
(Siemens Healthcare, Erlangen, Germany) using a 31-channel receive coil and 10-
channel head-only transmit coil for transmission (Figure 10). 
Three different sequences were used:  Turbo spin-echo (TSE) 3D (SPACE)-725um 
isotropic (Iso) sequence, fluid attenuated inversion recovery (FLAIR) 3D-800um Iso 
sequence and magnetization-prepared rapid gradient echo (MPRAGE)-750um Iso 
sequence. The acquisition parameters for the TSE 3D sequence were TR = 3750ms and 
TE = 435ms, with a bandwidth of 463Hz. Scan orientation was axial and sagittal for this 
sequence and the scan duration 7 minutes and 52 seconds.  The parameters for the FLAIR 
sequence were TR = 6000ms and TE = 269ms, with a bandwidth of 625Hz and Inversion 
Recovery pulse. Scan orientation was sagittal for this sequence and the scan duration 9 
minutes and 54 seconds. The MPRAGE parameters were TR = 7.78ms, TE = 2.57ms, a 
bandwidth of 260Hz, inversion recovery pulse and Sagittal scan orientation, for a total 
acquisition time of 6 minutes and 3 seconds. The MR sequences and parameters are 
outlined in Table 6.  
These sequences applied to the phantoms were the same sequences used later on the 
healthy subjects.  
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 Figure 10: The 7T MR magnet at Robarts Institute. 
2.2.5 Imaging postprocessing and measurements 
The obtained imaging was stored in nifti file format. Imaging post processing was 
performed with OsiriX image viewer (version 4.1.2 32-bit).  
With the aim of defining the spatial resolution of the system (i.e, the ability to 
discriminate between two adjacent image values or objects) and therefore calculate the 
size of the smallest vessel phantom that can be resolved with detail, and, to calculate 
objectively the accuracy and reliability of the obtained imaging we decided to measure 
the phantoms in both TSE 3D and FLAIR sequences. Since the MPRAGE was deemed to 
be an adjunctive angiographic sequence for the final protocol with subjects, the sequence 
was obtained to assess its feasibility but measurements were not performed. 
The saved images were loaded in the OsiriX viewer for its initial analysis and preparation 
for the measurements. This digital tool displays a 3-panel window containing sagittal, 
axial, and coronal reconstruction views  (3D MPR reconstruction) of the nifti data in 
addition to the corresponding model. In order to blind the measurements, every vessel 
was individualized and randomized. This way, the potential bias from measuring the 
phantom vessels directly from the whole 2D matrix model was avoided. The 
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individualization of the vessels was performed by selecting every vessel as the region of 
interest (ROI), propagating the selected ROI in the desired image range and nulling the 
pixels outside the ROI. With the vessel individualized and propagated, a single frame was 
selected for the measurements, exported as a DICOM (digital imaging and 
communications in medicine) format and stored. (Fig 11)   
       
Figure 11: 7T MR imaging of the 2D matrix phantom. a) FLAIR sequence b) TSE 3D 
sequence. On the bottom more detailed view of one of the rows in each sequence. 
Since by definition the reliability or precision of a measurement, also called 
reproducibility or repeatability, is the degree of stability exhibited when a measurement is 
repeated under identical conditions53-55, we chose 3 different observers to make the 
measurements. A previous training session was performed until each examiner felt 
comfortable with the use of electronic measurement tools on the OsiriX image viewer. A 
package with the image files, an Excel working sheet (Microsoft® Excel® version 12.0) 
and a scheme of the required measurements was provided (Fig 12). One of the observers 
performed the measurements 3 times on 3 different dates (intraobserver) while the other 
two only once (interobserver).   
21 
 
 
 
Figure 12: Scheme of how measurements were performed (OD, ID and vessel wall 
diameters). This model was provided to every observer. a) Measurements done on acquired 
phantom image. b) Graphic representation of the measurements. 
The accuracy of a measurement is defined as the estimate measuring of the true value54-
56. In our case, the degree of closeness of measurements of the obtained images to the 
actual (true) value. To define our dimensional truth, physical measurements of the 
phantoms were performed using a high-precision digital caliper (Pro-point. Metal 
Fractional digital caliper ) that measured up to 0.1mm (accuracy +/-0.3mm, Repeatibility 
+/-0.01mm, range 0-150mm). Detailed measurements were achieved with the aid of a 
surgical microscope  (OPMI PENTERO® 900 surgical microscope. Carl Zeiss Meditec) 
(Figure 13). The measurements of the phantom were performed using a replication of the 
2D matrix phantom that was scanned. That allowed an easier and more precise 
measurement  by enabling the sectioning of the PVA vessels to obtain cross-sectional 
measurements. This sectioning was performed with a pathology trimming knife (4786-
Trimming Knife. Tissue-Tek® Accu-Edge. Sakura Finetec USA, Inc. Torrance, CA, 
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USA). Measurements were performed twice and the mean of the 2 measurements was 
designated as the reference standard or dimensional truth. 
 
Figure 13: a) Digital caliper (range 0-150mm). b) Microscope screenshot showing cross-
sectional view of one of the PVA phantoms mounted on its respective rod. 
2.2.6 Statistical Analysis 
All statistical analysis and data processing were performed with a standard statistical 
software Package, SPSS statistical program version 15.0 for Windows (SPSS, Inc, 
Chicago, Illinois).  
Means, standard deviations and 99% confidence levels were calculated for all the 
measurements, including direct caliper measurements and imaging measurements by the 
observers. As a measure of reliability, the intraclass correlation coefficient (ICC) for 
absolute agreement based on a 2-way random effects analysis of variance (ANOVA) was 
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calculated. ICCs of the repeated imaging measurements tested the reliability of the 
measurements. Interobserver reliability of the measurements was determined by 
comparison of the measurements of the 3 observers. Intraobserver reliability of the 
measurements was determined by comparison of the repeated measurements of observer 
1. Because the direct caliper measurements were regarded as the reference; the accuracy 
of the system was determined by comparison of the observers measurements to the direct 
caliper measurements. ICCs of these 2 different measuring methods were obtained. A 
table of confidence intervals (CI 99%) was created. Cronbach’s Alpha was calculated as a 
measure of internal consistency.  
In order to determine the image resolution threshold, multiple comparisons between the 
measurements according to the caliber and according to the diameter of the vessel wall 
were calculated using the Wilcoxon Signed Ranks Test for paired variables. Results were 
adjusted for multiple comparisons using the Bonferroni adjustment procedure. 
2.3 Results 
MR images of the vessel phantoms revealed high contrast between the  high signal of the 
PVA-C phantoms and the low signal of  the acrylic-like rod inner lumen and the medium-
intensity agarose background. Better definition and contrast imaging of the vessel 
phantoms was obtained with TSE imaging comparing with the FLAIR sequence. 
Quantification of vessel dimensions (OD, ID and wall thickness) was feasible in all 27 
vessels (24 phantoms + 3 pig vessels) for both sequences. 
PVA-C mimicked the imaging characteristics of the vascular tissue remarkably well at 7T 
MR, both in TSE and FLAIR sequences, when compared with the imaging of the pig 
vessels included in the model (Fig 14)  
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 Figure 14: Detailed view comparing PVA-C phantom and pig vessel imaging at 7T (TSE) 
 
2.3.1 Accuracy and reliability: Validation of the system 
2.3.1.1 Reliability 
Measurements made by the observers over the phantom imaging were overall very 
reliable. Outside diameter and inner diameter measurements showed the highest 
agreement in both series (ICC: 0,987-0,998). High reliability was mantained for the wall 
diameter measurements in TSE sequences (ICC: 0,858-0,950). However, in FLAIR 
sequences the reliability of the measurements decreased significantly (ICC: 0,675-0,819), 
showing more variability of vessel wall diameter measurements. Interobserver and 
intraobserver reliability showed minor differences, with TSE sequence measurements 
being more reliable on average. The interobserver reliability for the vessel wall thickness 
in TSE was high with a mean ICC of 0,923 (0,832-0,955; 95% CI). Intraobsever repeated 
measurements were also very precise in TSE sequence with a mean ICC of 0,892 (0,764-
0,955; 95% CI).  For the FLAIR Imaging the interobserver correlation for wall diameter 
measurements was less consistent with a mean ICC of 0,742 (0,421-0,883; 95% CI). 
Intraobserver measurements also showed increased variability with an average ICC of 
0,767 (0,485-0,894; 95% CI). High internal consistency of the measures was 
demonstrated with a Cronbach's alpha of 0,874. Reliability is reported in a detailed 
intraclass correlation coefficients (ICC) table (see table 2). 
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Table 2: Intraclass correlation coefficients (ICC); interobserver and intraobserver reliability (average 
measures of OD, ID and Wt (lower bond-upper bond) 95% CI) for TSE and FLAIR sequences.  
 
2.3.1.2 Accuracy 
There was close agreement between MR derived measurements and phantom dimensions 
overall. The highest agreement was shown by outside diameter and inner diameter 
measurements in both TSE and FLAIR sequence (ICC: 0,983-0,997). Consistently with 
the reliability results, high closeness between the dimensional “truth” and the MR 
measurements was observed for the vessel wall measurements in TSE sequence with a 
mean ICC of 0,869 (0,698-0,944; 95% CI). FLAIR measurements showed a remarkable 
decrease in agreement values for vessel wall measurements with a mean ICC of 0,630 
(0,156-0,842), showing significant variability. Accuracy is reported in detail in an 
intraclass correlation coefficients (ICC) table (see table 3). 
TSE	   	  	  	  	  	  Observer	  1	  (1)	   Observer	  1	  (2)	   Observer	  1	  (3)	   Observer	  2	   Observer	  3	  
OD	   0,997	  (0,994-­‐0,999)	   0,996	  (0,991-­‐0,998)	   0,997	  (0,994-­‐0,999)	   0,998	  (0,995-­‐0,999)	   0,996	  (0,990-­‐0,998)	  
ID	   0,994	  (0,986-­‐0,997)	   0,993	  (0,985-­‐0,997)	   0,998	  (0,996-­‐0,999)	   0,997	  (0,994-­‐0,999)	   0,993	  (0,984-­‐0,997)	  
Wt	   0,837	  (0,642-­‐0,925)	   0,827	  (0,619-­‐0,921)	   0,925	  (0,835-­‐0,966)	   0,921	  (0,826-­‐0,963)	   0,885	  (0,748-­‐0,947)	  
FLAIR	   	  Observer	  1	  (1)	   Observer	  1	  (2)	   Observer	  1	  (3)	   Observer	  2	   Observer	  3	  
OD	   0,990(0,978-­‐0,995)	   0,992	  (0,984-­‐0,997)	   0,989	  (0,977-­‐0,995)	   0,987	  (0,972-­‐0,994)	   0,987	  (0,971-­‐0,994)	  
ID	   0,994	  (0,986-­‐0,997)	   0,996	  (0,942-­‐0,998)	   0,991	  (0,981-­‐0,996)	   0,989	  (0,976-­‐0,995)	   0,993	  (0,985-­‐0,997)	  
Wt	   0,675	  (0,287-­‐0,852)	   0,807	  (0,572-­‐0,913)	   0,819	  (0,597-­‐0,918)	   0,732	  (0,410-­‐0,878)	   0,727	  (0,369-­‐0,876)	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A graphical illustration of mean measurements (MR derived measurements + phantom 
dimensions) expressed as a table of confidence intervals (99% CI) is shown in Fig 15. 
Table 4 shows mean of measurements expressed as absolute means and standard 
deviations (SD). 
Table 3: Intraclass correlation coefficients (ICC); agreement of MR derived measurements (TSE and 
FLAIR sequences) compared to reference values (phantom dimensions).  
 
 
TSE	   	  	  	  	  	  Observer	  1	  (1)	   Observer	  1	  (2)	   Observer	  1	  (3)	   Observer	  2	   Observer	  3	  
OD	   0,986	  (0,967-­‐0,994)	   0,982	  (0,958-­‐0,992)	   0,984	  (0,962-­‐0,993)	   0,983	  (0,960-­‐0,992)	   0,978	  (0,950-­‐0,991)	  
ID	   0,998	  (0,996-­‐0,999)	   0,997	  (0,992-­‐0,998)	   0,998	  (0,994-­‐0,999)	   0,998	  (0,994-­‐0,999)	   0,995	  (0,987-­‐0,998)	  
Wt	   0,894	  (0,755-­‐0,954)	   0,865	  (0,689-­‐0,942)	   0,817	  (0,577-­‐0,921)	   0,878	  (0,719-­‐0,947)	   0,892	  (0,749-­‐0,953)	  
FLAIR	   	  	  	  	  	  Observer	  1	  (1)	   Observer	  1	  (2)	   Observer	  1	  (3)	   Observer	  2	   Observer	  3	  
OD	   0,978	  (0,948-­‐0,990)	   0,971	  (0,933-­‐0,987)	   0,964	  (0,958-­‐0,985)	   0,965	  (0,918-­‐0,985)	   0,968	  (0,927-­‐0,986)	  
ID	   0,996	  (0,991-­‐0,998)	   0,994	  (0,986-­‐0,997)	   0,995	  (0,988-­‐0,998)	   0,987	  (0,971-­‐0,995)	   0,990	  (0,977-­‐0,996)	  
Wt	   0,714	  (0,339-­‐0,876)	   0,501	  (0,154-­‐0,784)	   0,622	  (0,127-­‐0,837)	   0,666	  (0,228-­‐0,856)	   0,672	  (0,242-­‐0,858)	  
Table 3  
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Figure 15: Graphical illustration of mean measurements (MR derived + phantom dimensions) for OD, ID and Wt        
in both sequences (TSE and FLAIR) expressed as a table of confidence intervals (99% CI).  
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Table 4: Mean of measurements (MR derived measurements and phantom dimensions) expressed as absolute means 
and standard deviations (SD). 
 
2.3.2 Correlation by caliber and wall thickness.  
Evaluation of OD and ID measurements showed no significant differences related to 
decreasing vessel caliber. Both, TSE and FLAIR sequences, showed ICC results 
maintained constantly over 0,9 (0,985-0,999) with high internal consistency measured by 
Cronbach’s alpha >0,9 (0,960-0,977).    
In regards to vessel wall, when assessing the level of correlation of measurements in 
relation to the caliber of the phantoms, despite that the small size of the study sample did 
TSE	   Dimensional	  
truth	  (digital	  caliper)	   	  Observer	  1	  (1)	   Observer	  1	  (2)	   Observer	  1	  (3)	   Observer	  2	   Observer	  3	  OD	   4,44	  	  +/-­‐	  2,00	  mm	   5,13	  	  +/-­‐	  1,69	  mm	   5,18	  	  +/-­‐	  1,67	  mm	   5,13	  	  +/-­‐	  1,67	  mm	   5,04	  	  +/-­‐	  1,65	  mm	   5,30	  	  +/-­‐	  1,66	  mm	  
ID	   3,00	  	  +/-­‐	  1,47	  mm	   2,	  71	  	  +/-­‐	  1,47	  mm	   3,08	  	  +/-­‐	  1,44	  mm	   3,22	  	  +/-­‐	  1,45	  mm	   2,85	  	  +/-­‐	  1,45	  mm	   2,87	  	  +/-­‐	  1,44	  mm	  
Wt	   0,72	  	  +/-­‐	  0,44	  mm	   1,08	  	  +/-­‐	  0,34	  mm	   1,05	  +/-­‐	  0,25	  mm	   0,97	  	  +/-­‐	  0,25	  mm	   1,03	  	  +/-­‐	  0,27	  mm	   1,13	  	  +/-­‐	  0,33	  mm	  
FLAIR	   Dimensional	  
truth	  (digital	  caliper)	   	  Observer	  1	  (1)	   Observer	  1	  (2)	   Observer	  1	  (3)	   Observer	  2	   Observer	  3	  OD	   4,53	  	  +/-­‐	  2,05	  mm	   5,54	  	  +/-­‐	  1,74	  mm	   5,76	  	  +/-­‐	  1,64	  mm	   5,66	  	  +/-­‐	  1,71	  mm	   5,60	  	  +/-­‐	  1,60	  mm	   5,46	  	  +/-­‐	  1,67	  mm	  
ID	   3,02	  	  +/-­‐	  1,51	  mm	   3,19	  	  +/-­‐	  1,41	  mm	   3,62	  	  +/-­‐	  1,42	  mm	   3,47	  	  +/-­‐	  1,47	  mm	   2,73	  	  +/-­‐	  1,32	  mm	   3,31	  	  +/-­‐	  1,39	  mm	  
Wt	   0,75	  	  +/-­‐	  0,41	  mm	   1,07	  	  +/-­‐	  0,23	  mm	   1,08	  	  +/-­‐	  0,16	  mm	   1,06	  	  +/-­‐	  0,17	  mm	   1,37	  	  +/-­‐	  0,22	  mm	   1,06	  	  +/-­‐	  0,23	  mm	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not provide sufficient statistical power, also due to the high variability of vessel 
diameters, a tendency to obtain more accurate and reliable measurements in larger vessels 
(8-4mm) was observed with both sequences. Accuracy and reliability decreased generally 
in vessels of a size equal to or less than 3 mm.  Internal consistency (Cronbach’s alpha) 
also diminished in this vessel caliber range. An illustrative graphic representation of this 
tendency is shown as a table of confidence intervals (99% CI). (see Fig 16)  
Specifically for intraobserver precision, FLAIR measurements showed high variability 
and the pattern noted respect association with vessel caliber was less evident. The ICCs 
tend to be poorer, around 0.7 on average with a Cronbach’s alpha of 0,72 to 0,88. TSE 
ICC analysis demonstrated less variability and superior results in general. Trend to ICC 
decrease in the 3mm-2mm caliber group was more evident in this sequence with mean 
ICC of 0,940 (0,936-0,944) for the larger vessels and a mean ICC of 0,760 for the smaller 
ones. Interobserver assessment revealed similar results, and again some consistent 
tendency to reduction in the precision for the 3mm/2mm vessel size group. The obtained 
results are summarized in a table of ICCs values (table 5).  
Analysis by groups of wall thickness (25%, 20%, 15%, 10%), associated or not to vessel 
caliber, showed no significant differences related to decreasing wall thickness, 
independently of the sequence.  Standard errors (SE) appeared to be more prominent for 
vessels equal to or smaller than 4mm and with a wall thickness equal to or less than 20%.  
However, no evidence of a consistent pattern was demonstrated with some variability of 
SE independently of the wall thickness group.  
The results were adjusted for multiple comparisons (Bonferroni adjustment test), with a 
total of 38 comparisons per each sequence (TSE and FLAIR), and this led us to have to 
accept as significant , p values equal to or less  than 0.05/38=0.0013. Hence, the lack  of 
sufficient statistical power.     
Nevertheless, these results showed a trend to decrease on precision and accuracy in 
vessels with caliber equal or smaller than 3mm, independently of the wall thickness.  
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Table 5: Intraclass correlation coefficients (ICC); average agreement by vessel caliber   
(TSE and FLAIR)  
TSE	   	  	  	  	  	  	  Intraobserver	   	  	  	  	  	  	  Interobsever	  
8mm/6mm	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,944	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,948	  
5mm/4mm	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,936	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,907	  
3mm/2mm	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,760	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,846	  
FLAIR	   	  	  	  	  	  	  Intraobserver	  	   	  	  	  	  	  	  Interobsever	  
8mm/6mm	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,797	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,743	  
5mm/4mm	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,807	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,791	  
3mm/2mm	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,670	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0,572	  	  
Table 3  
  Table 5: Intraclass correlati n coefficients (ICC); ssessment by vessel 
caliber groups.    
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Figure 16: Graphical illustration of mean measurements by caliber groups (8mm/6mm, 5mm/4mm, 3mm/2mm) 
expressed as a table of confidence intervals (99% CI).  
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Chapter 3  
3 Healthy volunteers 
3.1 Introduction 
3.1.1 Hypothesis and objectives 
We hypothesize that using an ultra high field (7T) magnetic resonance Imaging (MRI) a 
fine definition of intracranial vessels wall could be accomplished. 
The objective is to determine its feasibility by using and refining the 7T MRI protocol 
previously defined with the PVA-C vessel phantoms.  
3.1.2 Importance of (scanning) Healthy subjects 
Healthy volunteers have always played a vital role in medical research. They provide 
researchers with crucial data because their health information can be used as a base line 
for comparison. In some studies, researchers need to compare healthy volunteers with 
people who have a specific disease or condition, while when developing a new technique 
such as a blood test or imaging method or device, clinical research volunteers are needed 
to help define the limits of "normal." Research with healthy volunteers is primarily 
designed to develop new knowledge, and rarely provides direct benefit to study 
participants. 
In our study, participants were subjected to an initial 7T MR protocol that was set up with 
the use of PVA-C phantoms as previously described. The information obtained imaging 
the volunteers should help to demonstrate the capabilities of 7T MRI to obtain detailed 
images of the intracranial vessels and serve as a starting point for future studies, based on 
the definition of the limits of normality, as well as for future comparisons with patients 
with intracranial vascular disease, and to improve imaging quality, definition and 
accuracy.  
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3.2 Methods 
3.2.1 Subjects characteristics and demographics 
10 healthy subjects (4 male, 6 female) in a determined group of age (26-34 years, Mean: 
29.8, Median: 28) underwent a head 7T MRI applying the previously developed protocol. 
Patients were placed in supine position. The scanning session lasted approximately 50-60 
minutes. The total length of each visit lasted less than 1.5 hours including consent, filling 
forms and screening. No incidental findings were noted when these volunteer subjects 
were scanned. All clinical subjects were healthy, ambulatory with no compromised 
functions.  
Volunteers were recruited by means of advertisements distributed in the LHSC 
University Hospital and Western University campus. On the basis of their responses to 
questionnaires administered at screening before MR imaging about medical condition and 
history (see appendix 2), volunteers showed no evidence of medical abnormalities or 
contraindications for the MR scan. Prior to testing, the nature and purpose of the study, 
and the details of the test, including possible risks or discomforts, were explained to each 
volunteer, and informed consent was obtained. 
3.2.2 Imaging of the healthy volunteers 
MRI scanning was carried out on the same 7T MR suite used to scan the phantoms (7T 
Agilant/Siemens human neuro system). The same three sequences used for the phantoms 
were replicated for the subjects: TSE 3D (SPACE)-725um Iso, FLAIR 3D-800um Iso 
and MPRAGE-750um Iso. The acquisition was in the sagittal plane with 64mm in the 
readout direction (S/I) for all the sequences. The acquisition parameters for the TSE 3D 
were TR = 3750ms and TE = 435ms, with a bandwidth of 463Hz. Scan duration was 7 
minutes and 52 seconds.  The parameters for the FLAIR sequence were TR = 6000ms 
and TE = 269ms, with a bandwidth of 625Hz and Inversion Recovery pulse. Scan 
duration was 9 minutes and 54 seconds. The MPRAGE parameters were TR = 7.78ms, 
TE = 2.57ms, a bandwidth of 260Hz and inversion recovery pulse, for a total acquisition 
time of 6 minutes and 3 seconds. The MR sequences and parameters are outlined in   
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table 6.  
Any and all of the 7T MR acquisitions performed during the study did not exceed the 
FDA safety levels for static magnetic field, SAR (Specific Absorption State), dB/dT, 
sound pressure level or peripheral nerve stimulation as outlined in Westerns MRI 
guideline 2-G-004. 
3.2.3 Image offline postprocessing and assessment 
The obtained imaging was stored in nifti file format. Offline post processing and visual 
assessment was performed with OsiriXTM image viewer (version 4.1.2 32-bit) and an 
offline workstation.  
The 3-dimensional (3D) reconstruction was used for final visualization to identify the 
vessel walls of the major arteries of the circle of Willis (COW) and its branches. This 3D 
format with isotropic resolution allowed multiple reformatting depending on local vessel 
orientation. It was sought to reorient perpendicular to the vessel under study, with the aim 
of better delineate the vessel wall boundaries (outboundaries), although it was not 
possible consistently, specially for distal vessels.  
Both FLAIR and TSE scans acquired were registered to the MPRAGE at 750um Iso 
(isotropic) to help with data postprocessing options in order to improve the contrast of the 
imaging. A matlab registration script was applied for this purpose using the “PuTTY” 
system as a terminal emulator. MPRAGE data was also used to identify the observed 
vessels on the TSE and FLAIR images.  
Measurements of vessel caliber (OD), lumen size (ID) and vessel wall diameter of the 
distal internal cerebral artery, basilar artery, M1 segment of the middle cerebral artery 
and P1 segment of the posterior cerebral artery were performed in all subjects. Means and 
standard deviations were calculated for all the measurements (table 7).  
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Table 6: 7T MR acquisition parameters. (*RO=Readout, *PE=Phase Encode, *PE2=2nd Phase Encode, 
Tx = Transmit, Rx = Receive) 
Parameters	   TSE_3D	  (SPACE)-­‐-­‐	  725um	  Iso	   FLAIR_3D	  -­‐-­‐	  800um	  Iso	   MPRAGE	  -­‐-­‐	  750um	  Iso	  
Scan	  Orientation	   Sagittal	   Sagittal	   Sagittal	  
TR	   3750ms	   6000ms	   7.78ms	  
Effective	  TE	   435.03ms	   269,19	   2.57ms	  (actual	  TE)	  	  
Matrix	  (ROxPExPE2)	   216x304x220	   80x200x200	   240x294x230	  
Acceleration	  Factor	  
(Total)	   2,82	   2,99	   2,36	  
Bandwidth	   463	  Hz/px	   625	  Hz/px	   260	  Hz/px	  
Field	  of	  View	  
(ROxPExPE2)	   156x220x160	   64x160x160	   180x220x172	  
Fat	  Saturation	   No	   no	   Yes	  
Inversion	  Recovery	   No	   yes	   Yes	  
Inversion	  Time	   NA	   1750ms	   450ms	  
Scan	  Time	   7min	  52sec	  (x2	  acquisitions)	   9min	  54sec	  (x2	  acquisitions)	   6min	  3sec	  (1	  acquisition)	  
Echo	  Spacing	   4.63ms	   3.99ms	   	  
Echo	  Train	  Length	   188	   135	   	  
Flip	  Angle	   Variable	  (target-­‐-­‐40degrees)	   Variable	  (target-­‐-­‐45degrees)	   10	  degrees	  
Coil	  *	   10ChTx	  /	  31ChRx	   10ChTx	  /	  31ChRx	   10ChTx	  /	  31ChRx	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3.3 Results 
3.3.1 TSE 3D 
 In TSE imaging, vessel wall of the distal internal cerebral artery, basilar artery, M1 
segment of the middle cerebral artery, A1 segment of the anterior cerebral artery, and P1 
segment of the posterior cerebral artery could be visualized and measured along their 
complete trajectories in all subjects (Fig 17,18). Also, in most volunteers the vessel wall 
of the proximal and smaller A2, M2, and P2 segments of the anterior cerebral artery, 
middle cerebral artery, and posterior cerebral artery, respectively, could be identified 
although with worse, irregular and non consistent definition along their course. It was 
significantly difficult to distinguish the vessel wall of these smaller branches, particularly 
when it was immediately adjacent to brain parenchyma. The quality of the vessel wall 
depiction decreased consistently with the vessel caliber. The best contour definition and 
wall depiction was observed in the ICA and Basilar branches where cross-sectional views 
were always accomplished and wall boundaries were less affected by brain tissue.  
Measurements of wall thickness ratio (OD/Wt) seemed to correlate with vessel wall 
thickness from prior studies36-47 (postmortem measurements), showing a range between 
14% to 28% (estimated intracranial vessel wall thickness from postmortem studies ≈15-
20% OD/Wt ratio). However absolute measurements appeared to be oversized in 
comparison with data from those studies. A comparison of means (t-student test, 95% CI, 
p<0,05) was performed between MR derived measurements of healthy subjects (n=10) 
and the average measurements of the literature sources (n≈100) and significant 
differences were identified in line with the suspected oversizing (see Table 7). Oversized 
measurement affected more significantly those vessels surrounded by brain parenchyma.  
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Figure 17: Detailed vessel wall view of anterior circulation arteries. a) ICA terminus (ICAT) 
b) ICA (cavernous segment). c) M1 (white arrow) and ICAT (red arrow). d,e)  MCA (M1). 
 
Figure 18: Detailed vessel wall view of posterior circulation. a) Basilar artery. b) PCA. c) 
Basilar artery cross-sectional measurement. d) Basilar artery sagittal view. 
38 
 
 
3.3.2 FLAIR 
In FLAIR imaging, vessel wall of distal internal cerebral artery and basilar artery could 
be visualized in all the subjects (Fig 19). However, vessel wall could not be visualized 
along their complete trajectories and distal branches (MCA, ACA and PCA). 
Measurements in these 2 intracranial segments gave the impression again to be 
overdimensioned in comparison with prior data from postmortem studies. Overall, it was 
a poor sequence to depict vessel wall beyond the proximal segments of the COW.  
 
Figure 19: FLAIR. Detailed cross-sectional view of the distal ICA. 
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   MR	  derived	  
measures	  
Average	  
literature	  
sources	  
	  
p	  
MR	  derived	  
measures	  
Average	  
literature	  
sources	  
	  
p	  
Vessel	   OD	   OD	   	   Wt	   Wt	   	  
	  ICA	  	  	  	  	  	  	  	  	  	  	  	  	  	  (Cavernous	  segment)	   5,26	  (±0,47)	   4,20	  (±0,90)	   <0,001	   1,16	  (±0,20)	   -­‐-­‐	   -­‐-­‐	  
ICA	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (terminus)	   4,26	  (±0.51)	   4.20	  (±0,90)	   0,863	   1,02	  (±0,15)	   -­‐-­‐	   -­‐-­‐	  
	  MCA	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (proximal	  M1)	   3,70	  (±0,51)	   2,96	  (±0,47)	   <0,001	   0,89	  (±0.17)	   0,51	  (±0,08)	   <0,001	  
Basilar	   4,25	  (±0,69)	   3,08	  (±0,42)	   <0,001	   0,87	  (±0,16)	   0,60	  (±0,12)	   <0,001	  
PCA	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (P1	  segment)	   3.20	  (±0,25)	   2.10	  (±0,70)	   <0,001	   0,99	  (±0,10)	   -­‐-­‐	   -­‐-­‐	  
                                                                                                                                                                                   
Table 7:  COW arteries diameters. Mean comparison between average MR measurements and 
average diameters described in the literature (expressed as mean +/- standard deviation, p<0,05). 
(OD: outside diameter, Wt: wall thickness, ICA: internal carotid artery, MCA: middle cerebral 
artery, PCA: posterior cerebral artery) 
 
3.3.3 MPRAGE 
The MPRAGE imaging was used as an adjunctive imaging tool to help improving the 
contrast of the imaging by realigning and co-registering to the other sequences, and also 
to better depict the corresponding vessels on the TSE and FLAIR images.   
MPRAGE imaging showed high resolution with excellent vessel-to-tissue contrast 
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allowing us to delineate the vessels far distally into the periphery and even discriminate 
small vessels like brain perforators (Fig 20).  
 
Figure 20: MPRAGE sequence. a) Axial view (COW). b) Axial view (Distal MCA branches). 
c) Coronal view (COW). d) Sagittal view (multiple intracranial vessels).    
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Chapter 4  
4 Discussion  
4.1 PVA-C phantoms: spatial resolution of the system. 
Aiming for an image resolution threshold.  
A measurement system is considered valid if it is both accurate and precise (reliable). 
Measurements recorded from the phantom showed overall high inter and intraobserver 
reliability and accuracy. However, accuracy and precision were affected by the imaging 
sequence, with TSE measurements being, in general, more accurate and precise.  
The reliability and accuracy were calculated and expressed as intraclass correlation 
coefficients (ICCs). In most research situations a reliability coefficient of 0,70 or higher 
is considered "acceptable", and some subjective guidelines suggest that an ICC from 0,81 
to 1 is desired and indicates an “almost perfect” agreement57.  
On average, in terms of reliability for vessel wall measurements, while TSE showed high 
agreement with a mean ICC ≥0,9, FLAIR demonstrated fairly high variability with mean 
ICC slightly >0,70. For accuracy, TSE showed again high closeness values (ICC: 0,869) 
while FLAIR showed a correlation coefficient below the “acceptable” limits (i.e. <0,7).   
This discrepancy in FLAIR sequences is consistent with the imaging contrast superiority 
of TSE for wall depiction demonstrated in the in-vivo imaging with healthy subjects.  
The results obtained, specially for TSE, demonstrate that the imaging protocol assessed 
with the PVA-C phantom construct was overall a valid model for intracranial vessel wall 
assessment under ideal and controlled conditions, such as vessel and wall size, orientation 
and lack of motion artifacts.  
Analysis of precision and accuracy as a function of vessel caliber and wall thickness was 
performed with the aim to define an image resolution threshold for intracranial vessels in 
the ideal conditions provided by the phantom. The obtained results, most likely due to a 
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lack of enough statistical power, did not allow us to draw a clear image resolution line 
with resounding significance. However, a trend for decreasing on accuracy and reliability 
was shown in vessels equal or smaller than 3mm. Interestingly, this was independent of 
the wall thickness expressed as a percentage (OD/Wt ratio %). Analysis by wall thickness 
showed no significant evidence of its impact in precision and accuracy. These findings 
suggest that the absolute vessel caliber, especially below certain size, is determinant in 
terms of accuracy and precision of the imaging. Therefore, is expected that precision 
below certain resolution threshold, that we estimate around 3mm, will be affected 
independently of the wall thickness, at least for the ratio range (25%-10%) explored in 
this study. It is unknown if wall thickness >25%, that could probably be expected for 
certain cerebrovascular pathologies, could impact positively and eventually improve the 
wall depiction precision.   
In the light of these results, and obviating other potential sources of imaging bias that 
could be expected in real conditions with subjects, it should be anticipated to find some 
difficulties for a fine, precise and accurate visualization of intracranial vessel wall of 
smaller vessels, particularly with diameters below 3mm, like anterior cerebral arteries, 
distal middle cerebral artery branches and, in general, distal vessels of the circle of 
Willis.    
4.2 Problems with subjects imaging: are we really seeing 
vessel wall? 
In this study we evaluated a 3-dimensional (2 sequences) 7T MRI protocol for 
intracranial vessel wall imaging of normal non-diseased intracranial arteries. A total of 10 
healthy subjects with not known cerebrovascular disease were scanned and vessel wall of 
the major intracranial arteries was consistently visible in all of them. However, the 
quality of vessel wall boundaries discrimination diminished correspondingly with 
decreasing in vessel caliber, and precise definition of distal COW segments was not 
satisfactorily achieved. It was particularly challenging to distinguish the vessel wall of 
these smaller branches, especially when surrounded by brain parenchymal tissue. 
Quantification analysis of major intracranial vessels was accomplished. The results of the 
43 
 
 
measurements, interestingly, showed calibers and vessel wall diameters significantly 
(p<0,05) overdimensioned in comparison with pre-existing intracranial vessel 
measurements from previous studies36-47, thus questioning the capability of accurate 
intracranial vessel boundaries definition.  
Several factors could affect vessel wall imaging and explain the difficulties to obtain 
clear wall boundaries definition, especially in distal intracranial vessels. Although in 
general, most of the subjects tolerated the acquisition time without problem, the 
acquisition times were relatively long (7.5 to 9.5 minutes) and imaging could be limited 
by motion artifacts. These artifacts are more common during long image acquisitions, and 
can be caused by breathing motion, cardiac and brain pulsation, CSF flow at the 
subarachnoid spaces and involuntary head movements58. Small motions, even below 1 
mm, can result in obvious degradation of image quality and decrease the image resolution 
for finer details such as vessel wall59. There may also well be partial volume effects 
particularly in vessels immediately adjacent to brain parenchyma, which may increase the 
difficulty in obtaining reliable MRI measurements, leaning towards overestimation of the 
vessel wall limits. All the healthy volunteers in our study were young (mean <30 years, 
range 26-34). Previous studies by van der Kolk5,20  showed that the vessel wall was more 
clearly visible in older healthy volunteers (and in diseased vessels). These findings could 
be a consequence of normal aging of the vessel or asymptomatic vessel wall pathology, 
and infer absence of significant atrophy in young subjects, making vessel wall depiction 
more difficult.  
Efforts were also made to reduce the potential imaging contrast lost related to lack of 
sufficient contrast between vessel wall and surrounding CSF. The FLAIR sequence was 
performed with the aim of nulling CSF signal expecting to obtain significant contrast 
between vessel wall and adjacent CSF and/or explore the possibility of fuse or combine 
the data with the TSE in postprocessing and therefore completely remove the CSF in the 
TSE sequence. However none of the applied scripts resulted in significant improvements 
in contrast imaging, and FLAIR sequence showed no capability to image vessel wall 
beyond the ICA and basilar segments. This could also be related to the limited coverage 
of the FLAIR sequence (centered in the major COW arteries) in order to avoid longer 
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acquisition times, prolonging the time volunteers had to remain completely still. Overall, 
TSE demonstrated to be superior on vessel wall imaging contrast compared with FLAIR. 
Although high field 7T MR represents a significant improvement in spatial resolution our 
results suggest there is still lack of certainty of accurate visualization of vessel wall, and, 
even though different sequence optimization and efforts have been made in ours and 
previous studies5,20,21 there is still the potential for vessel overestimation due to partial 
volume effects as mentioned before. Some studies demonstrated the tendency for wall 
thickness overestimation due to partial volume errors using MRI59-62. This suspected bias 
has been investigated and qualitatively described in carotid arteries and intracranial 
aneurysm at 3T MRI59-61. The accuracy limits of thickness determination in 3T MR 
images was investigated by Sato et al.62 and their results showed the measured thickness 
was overestimated by around 10%. Our wall measurements go in line with these 
publications, and, albeit increased SNR should diminished this effect in light of a higher 
spatial resolution, the potential for vessel wall oversizing should be taken into account for 
future protocol optimizations and vessel wall studies in patients with cerebrovascular 
disease.        
4.3 MPRAGE: 7T non-enhanced MR angiopraphy 
In our study MPRAGE was revealed, almost as an incidental finding, as a high-resolution 
non-enhanced magnetic resonance angiography (MRA).  
It has been shown that MPRAGE sequence provides high signal intensity of blood 
vessels on contrast-enhanced images at 1.5T and 3T MR. However, it has no sufficient 
arterial vasculature signal when contrast agent is not administered. Therefore, other 
sequences have been used in order to obtain a non-enhanced MR angiography, being the 
time of flight (TOF) MRA the most commonly used. TOF MRA at 1.5T and 3T has 
evolved overtime to become a fairly reliable noninvasive angiographic technique, which 
is regularly used for detection and follow-up of some intracranial vascular pathologies 
like aneurysms.  
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When imaging at 7T, it has been observed that the MPRAGE sequence provides high 
signal in the arterial vasculature while the background shows intermediate signal, 
resulting in high vessel-to-background contrast potential23,63-65. That resolution enables 
the intracranial vessels to be traced and delineated far into the periphery23. Such 
intracranial vessel resolution on MPRAGE sequence, without contrast agent 
administration, is only possible with ultrahigh field strength MR23,66. Moreover, when 
comparing the non-enhanced MPRAGE sequence at 7T with the potential benefit of 
adding contrast to it, studies revealed only minor or non-significant improvement66,67.  
A recent study66 also demonstrated the superiority of 7T MPRAGE over 7T (and 1.5T) 
TOF MRA in terms of image quality, vessel delineation and capability for simultaneous 
high quality assessment of related anatomical parenchymatous structures.  
The MPRAGE imaging obtained in this study, goes in line with previous investigations, 
showing remarkably high resolution and excellent vessel-to-tissue contrast, which 
allowed us to identify the primary vessels of the COW and follow them distally along 
their course into the brain parenchyma. The resolution was such that it was feasible to 
even discriminate small vessel structures like perforating arteries. Due to the nature and 
primary objectives of the study, no comparison with other non-enhancing angiographic 
techniques neither with the gold standard angiography, digital subtraction angiography 
(DSA), was performed. Nevertheless, we believe that our imaging results and previous 
publications63-68 underline the high diagnostic and potential clinical application of 7T 
MPRAGE non-enhanced angiography for evaluation, management, screening and follow-
up of several intracranial vasculopathies.    
4.4 Limitations of the study 
4.4.1 PVA-C phantom model 
This study has several limitations. First, the model used to define our dimensional truth 
was a replica of the 2D matrix phantom that was scanned but not the original phantom 
itself. While the supporting fixture for the vessel phantoms, made in acrylic-like material, 
is less likely to significantly change in a replication, due to the nature of PVA-C and the 
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different factors involved in its process, it is impossible to completely ensure non 
substantial changes in one or several vessel phantoms. Second, in the original model, 
phantoms were surrounded by agarose gel, which could discretely affect the vessel 
phantom boundaries for its measurement, while the replicated model was not embedded 
in agarose. Third, for the ease and precision of the measurements the phantoms were 
sectioned in order to obtain cross-sectional measurements. The very act of sectioning the 
PVA phantoms may lead to tissue or wall deformations that result in underestimation of 
the measurement. Fourth, although the physical measurements of the phantoms were 
performed using a high-precision digital caliper with the adjunctive help of a surgical 
microscope for better visualization, considering the elastic properties of the PVA-C and 
the remarkably small caliber of some of the vessels, the same act of measuring could 
represent some wall deformation which could lead to underestimate the measurements. 
Fifth, another potential source of error and/or bias could be related to the fact that we 
used the mean average of the measurements for the ease of the statistical analysis. This is 
subjected to the assumption that the wall thickness is uniform in each vessel.  Sixth, the 
individualization of the vessels for their measurements could also represent some bias, 
given the fact that FLAIR imaging was acquired exclusively in sagittal, whereas the TSE 
was acquired also in axial, making the process of individualization, propagation and 
frame selection more tedious, difficult and probably less precise. As a result this could 
discretely impact in the final quality of each vessel imaging for the FLAIR sequence.  
4.4.2 Healthy Subjects 
In terms of subject imaging the current study has some limitations as well. Intracranial 
vessels show tortuous course and don’t have a single orientation. Consequently, thick 
slices perpendicular to the vessel orientation were not possible. During postprocessing 
assessment (3D reconstruction) it was attempted to reorient perpendicular to the vessel 
under study to better define the vessel wall limits but it was not feasible for each vessel, 
affecting predominantly distal branches. Thus, some vessel obliqueness could lead to 
measurement errors. It was difficult to distinguish the vessel wall boundaries in vessels 
immediately adjacent to brain parenchyma and there may well be partial volume effects, 
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particularly for smaller branches embedded into brain parenchymal tissue, which may 
increase the difficulty of obtaining reliable MRI measurements and leading to their 
overestimation. Along with the beneficial increase in SNR, 7T also provides an increased 
artifact-to-noise-ratio (ANR). We used relatively long acquisition times, and imaging 
could be limited by motion artifacts. Imaging could also be affected by susceptibility 
artifacts. The presence of these artifacts, even if minor, could decrease the image 
resolution for finer details like vessel wall depiction. No specific cerebrospinal fluid 
suppression (CSF) method was used in TSE sequence during acquisition to improve 
contrast between cerebrospinal fluid and vessel wall, and therefore minimize possible 
misinterpretation of cerebrospinal fluid signal around a vessel for signal from the vessel 
wall. Postprocessing imaging was performed to fuse or combine the 2 sequences (TSE 
and FLAIR) and obtain improvement in contrast image and null the CSF signal but the 
results were non significantly better and/or unsatisfactory. Measurements of vessel 
diameters in healthy subjects were made by a single observer. Due to the high anatomic 
course variability and the required reorientation in most of the vessels to improve wall 
boundary definition for its measurement, the imaging postprocessing preparation it was 
deemed too complicated and observer dependent, and therefore subjected to bias. 
Consequently, no assessment of reliability for these measurements was made.  There was 
no dimensional “truth” or standard reference for these measurements, although average 
data of previous postmortem studies was used as a reference for comparison.  
4.5 Strengths of the study 
There are four major strengths to this study. First, rather than proceeding with the 
assumption that 1.5 and 3T protocols would directly import to 7T, a protocol was defined 
as an initial stage, using an ex vivo phantom model that allowed us to infer an image 
resolution threshold for intracranial vessels in ideal and controllable conditions. Second, 
this study represents the first experience with PVA-C as a mimicking tissue material in 
7T MR and we demonstrated its ability to mimic vascular tissue imaging properties at 
high field MRI. Third, this study is the first attempt to quantify intracranial vessel wall 
diameters and compare it to the existing literature data while questioning the capability of 
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depict exclusively vessel wall at 7T MR.  Previous existent publications described their 
findings qualitatively, but none of the previous existent publications attempted 
quantification of the vessel diameters. Moreover, the design of the study evaluated vessel 
wall exclusively in healthy subjects (mean age <30) with the aim to obtain a base line 
assessment from non-diseased or aged vessels. Fourth, although it was not the goal of the 
study, MPRAGE imaging demonstrated high resolution and showed its potential for an 
immediate clinical use as a non-enhanced MR angiography.  
4.6 Future directions 
Our results showed that vessel wall imaging is feasible. However, continuous research in 
order to better delineate the vessel wall boundaries and to visualize smaller and distal 
intracranial vessels is needed. Increasing knowledge and experience with brain imaging 
at 7T, improvement in coil designs and system upgrades will result in wider and better 
applicability. Immediate clinical usability of these technique it has not been demonstrated 
in this study, moreover, current regulations and safety rules regarding subject MRI at 
ultra high field strength are very strict when concerning metallic implants, like stents or 
surgical clips, which are not uncommonly present in patients with cerebrovascular 
disease. These patient contraindications imply a limited number of patients who could 
undergo imaging at 7T MR currently.  
Nevertheless, future directions include application of these vessel wall imaging 
techniques to evaluate vessel wall in patients with intracranial vascular disease, 
particularly patients affected by intracranial atherosclerosis and patients with vascular 
malformations like aneurysms. Identify aneurysm wall thickness (AWT) could lead to 
estimate the risk of intracranial aneurysm rupture and provide a relevant information for 
its clinical management.  
In future, vessel wall imaging at 7T will help to resolve the current limited imaging 
diagnosis of intracranial vessel wall abnormalities and vasculopathies.   
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Chapter 5  
5 Conclusion 
This study demonstrated the feasibility of vessel wall imaging at 7T MR using a TSE 3D 
(SPACE) sequence. However, precision and definition decreased correspondingly with 
the vessel caliber and surrounding brain tissue presence. Vessel wall tended to be 
overestimated most likely due to partial volume effects.  
We also showed that PVA-C is a good vascular phantom material for ultra high-field MR 
studies that adequately mimicked intracranial vessel wall imaging properties. A trend to 
decrease in precision and accuracy for smaller vessels (<3mm) was also seen from the 
phantom.  
MPRAGE sequence used to facilitate the tracing of the intracranial vessels revealed high 
resolution and its immediate future as a non-enhanced angiographic technique is 
expected.  
These results are promising, and further investigation in patients with cerebrovascular 
disease is warranted.  
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